Skip to Main Content

Author Details

Oliver Laeyendecker
Department of Medicine Johns Hopkins Medicine. Baltimore MD 21205USA.
1996
269
51
PMIDPaper TitleJournal TitlePublished Year
37380166Orthopoxvirus-Specific T-Cell Responses in Convalescent Mpox Patients.J Infect Dis2024
36824860Early Treatment, Inflammation and Post-COVID Conditions.medRxiv2023
37659419Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study.Lancet Microbe2023
37744365Comprehensive profiling of pre-infection antibodies identifies HIV targets associated with viremic control and viral load.Front Immunol2023
37544771High level of HIV viral suppression in a cross-sectional study of Ugandan men with urethritis and bacterial STI.Int J STD AIDS2023
37534607Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trials.Transfusion2023
37637232Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in Baltimore, Maryland.Drug Alcohol Depend Rep2023
35579509Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial.Clin Infect Dis2023
36993261Longitudinal population-level HIV epidemiologic and genomic surveillance highlights growing gender disparity of HIV transmission in Uganda.medRxiv2023
37255467SARS-CoV-2 seroprevalence among blood donors in Uganda: 2019-2022.Transfusion2023
37079374Age Patterns of HSV-2 Incidence and Prevalence in Two Ugandan Communities: A Catalytic Incidence Model Applied to Population-Based Seroprevalence Data.J Infect Dis2023
37131659Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial.medRxiv2023
36625657Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment.mBio2023
36868260HIV incidence and mortality in transgender women in the eastern and southern USA: a multisite cohort study.Lancet HIV2023
34293114The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV).Clin Infect Dis2022
35679259Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals.PLoS One2022
35443020Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern.Blood Adv2022
35349483IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function.JCI Insight2022
35402002Phylogenetic estimation of the viral fitness landscape of HIV-1 set-point viral load.Virus Evol2022
35833684Decay of coronavirus disease 2019 mRNA vaccine-induced immunity in people with HIV.AIDS2022
35389888SARS-CoV-2-specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge.JCI Insight2022
35415200Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Decedents Undergoing Forensic Postmortem Examination: Feasibility for ⿨Real-Time Pandemic Surveillance.Open Forum Infect Dis2022
35353960Early Outpatient Treatment for Covid-19 with Convalescent Plasma.N Engl J Med2022
36368950Evaluation of multi-assay algorithms for cross-sectional HIV incidence estimation in settings with universal antiretroviral treatment.BMC Infect Dis2022
36332653Impact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2: a prespecified secondary outcomes analysis of the HPTN 071 (PopART) community-randomised trial.Lancet HIV2022
35891568Evaluation of the HIV-1 Polymerase Gene Sequence Diversity for Prediction of Recent HIV-1 Infections Using Shannon Entropy Analysis.Viruses2022
36346452Multiple Infection and Human Immunodeficiency Virus Superinfection Among Persons who Inject Drugs in Indonesia and Ukraine.J Infect Dis2022
33866544Regression with interval-censored covariates: Application to cross-sectional incidence estimation.Biometrics2022
35189840Severe Acute Respiratory Syndrome Coronavirus-2 seroprevalence in South-Central Uganda, during 2019-2021.BMC Infect Dis2022
35044204Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency Department.J Clin Microbiol2022
35169815Differential antibody production by symptomatology in SARS-CoV-2 convalescent individuals.medRxiv2022
35229637Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8<sup>+</sup> T-Cell Epitopes Identified in COVID-19 Convalescent Individuals.mBio2022
35104245Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection.JCI Insight2022
33208477Evaluation of Serological SARS-CoV-2 Lateral Flow Assays for Rapid Point-of-Care Testing.J Clin Microbiol2021
33769768The HIV Screening Cascade: Current Emergency Department-Based Screening Strategies Leave Many Patients With HIV Undiagnosed.J Acquir Immune Defic Syndr2021
33493365ABO blood group and SARS-CoV-2 antibody response in a convalescent donor population.Vox Sang2021
33880484Differential Performance of CoronaCHEK SARS-CoV-2 Lateral Flow Antibody Assay by Geographic Origin of Samples.medRxiv2021
33879585Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma.mBio2021
33571169Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality.J Clin Invest2021
33903166Differential Performance of CoronaCHEK SARS-CoV-2 Lateral Flow Antibody Assay by Geographic Origin of Samples.J Clin Microbiol2021
33594378CD8+ T cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variants.medRxiv2021
33674212A high prevalence of potential HIV elite controllers identified over 30 years in Democratic Republic of Congo.EBioMedicine2021
33532806Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers.medRxiv2021
33499732Short Communication: Validation of the Asante HIV-1 Rapid Recency Assay for Detection of Recent HIV-1 Infections in Uganda.AIDS Res Hum Retroviruses2021
33660319A top scoring pairs classifier for recent HIV infections.Stat Med2021
34981068Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma.medRxiv2021
34909772Minimal cross-over between mutations associated with Omicron variant of SARS-CoV-2 and CD8+ T cell epitopes identified in COVID-19 convalescent individuals.bioRxiv2021
34931202Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection.medRxiv2021
34897992Validation of population-level HIV-1 incidence estimation by cross-sectional incidence assays in the HPTN 071 (PopART) trial.J Int AIDS Soc2021
34671778Differentiation of SARS-CoV-2 naturally infected and vaccinated individuals in an inner-city emergency department.medRxiv2021
  • 1 - 50 of 269

Recommended Authors

Yale School of Medicine, Yale University
Career Start Year 2014
Number of shared co-authors 0
University of Nebraska Medical Center
Career Start Year 2011
Number of shared co-authors 0
University College London Hospitals National Health Service Foundation Trust
Career Start Year 2010
Number of shared co-authors 0
University of North Carolina at Chapel Hill
Career Start Year 2010
Number of shared co-authors 1
School of Public Health, Brown University
Career Start Year 2007
Number of shared co-authors 1
University of Washington
Career Start Year 2007
Number of shared co-authors 3
Vitalant Research Institute
Career Start Year 2003
Number of shared co-authors 7
University of California san francisco
Career Start Year 2002
Number of shared co-authors 8
University of California San Diego
Career Start Year 2001
Number of shared co-authors 9
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 8
Rollins School of Public Health, Emory University
Career Start Year 2001
Number of shared co-authors 3
Northwestern University Feinberg School of Medicine
Career Start Year 2000
Number of shared co-authors 8
Lausanne University Hospital, University of Lausanne
Career Start Year 1999
Number of shared co-authors 2
The University of North Carolina School of Medicine
Career Start Year 1997
Number of shared co-authors 4
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 3
Harvard TH Chan School of Public Health
Career Start Year 1996
Number of shared co-authors 4
Kaiser Permanente San Francisco Medical Center
Career Start Year 1994
Number of shared co-authors 3
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Career Start Year 1993
Number of shared co-authors 10
Hospital Germans Trias i Pujol
Career Start Year 1992
Number of shared co-authors 4
Harvard School of Public Health
Career Start Year 1989
Number of shared co-authors 5
Instituto de Investigacion Hospital 12 de Octubre (imas12)
Career Start Year 1988
Number of shared co-authors 0
Scientific Affairs LLC
Career Start Year 1987
Number of shared co-authors 6
IF School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 6
University of Nebraska Medical Center
Career Start Year 1987
Number of shared co-authors 5
University of Washington
Career Start Year 1984
Number of shared co-authors 11
University of California San Francisco
Career Start Year 1981
Number of shared co-authors 8
University of Alabama at Birmingham
Career Start Year 1980
Number of shared co-authors 12
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 10
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1979
Number of shared co-authors 14
Graduate School of Public Health, University of Pittsburghgrid.21925.3d
Career Start Year 1976
Number of shared co-authors 3

Collaborators

Johns Hopkins University School of Medicine
Co-authored papers 57
Johns Hopkins University School of Medicine
Co-authored papers 34
Co-authored papers 33
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 32
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 24
Johns Hopkins School of Medicine, Johns Hopkins University
Co-authored papers 24
Johns Hopkins University School of Medicine
Co-authored papers 19
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 18
Johns Hopkins University School of Medicine
Co-authored papers 14
Johns Hopkins School of Medicine, Johns Hopkins University
Co-authored papers 13
Johns Hopkins University
Co-authored papers 10
Institute for Cell Engineering, Johns Hopkins University School of Medicine
Co-authored papers 10
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 9
David Geffen School of Medicine, University of California los angeles
Co-authored papers 8
Co-authored papers 7
Co-authored papers 7
Co-authored papers 7
Co-authored papers 6
MedStar Washington Hospital Center
Co-authored papers 6
University of New Mexico
Co-authored papers 6
University of Rochester Medical Center
Co-authored papers 6
Mayo Clinic Hospital
Co-authored papers 6
Johns Hopkins University
Co-authored papers 5
Wilmer Eye Institute, Johns Hopkins Medicine School of Medicine
Co-authored papers 5
Johns Hopkins University School of Medicine
Co-authored papers 4
Ecole Polytechnique Federale de Lausanne
Co-authored papers 4
Co-authored papers 4
Institute of Medical Virology, University of Zurich
Co-authored papers 4
Vitalant Research Institute
Co-authored papers 3
Johns Hopkins University School of Medicine
Co-authored papers 3